Share

April 2016; 3 (2) ArticleOpen Access

CNS accumulation of regulatory B cells is VLA-4-dependent

Klaus Lehmann-Horn, Sharon A. Sagan, Ryan C. Winger, Collin M. Spencer, Claude C.A. Bernard, Raymond A. Sobel, Scott S. Zamvil
First published March 9, 2016, DOI: https://doi.org/10.1212/NXI.0000000000000212
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
1040

Share

Article Information

vol. 3 no. 2 e212
DOI: 
https://doi.org/10.1212/NXI.0000000000000212
PubMed: 
27027096
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2332-7812
History: 
  • Received September 15, 2015
  • Accepted in final form January 7, 2016
  • First Published March 9, 2016.
Copyright & Usage: 
© 2016 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.

Author Disclosures

    1. Klaus Lehmann-Horn, MD,
    2. Sharon A. Sagan, BA,
    3. Ryan C. Winger, PhD,
    4. Collin M. Spencer, BS,
    5. Claude C.A. Bernard, PhD,
    6. Raymond A. Sobel, MD and
    7. Scott S. Zamvil, MD, PhD
  1. Klaus Lehmann-Horn, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Fellowship grant from the Deutsche Forschungsgemeinschaft (DFG; Le 3079/1-1)

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Fellowship grant from the US National Multiple Sclerosis Society (FG 2067-A-1)

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Sharon A. Sagan, BA,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Ryan C. Winger, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Collin M. Spencer, BS,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Claude C.A. Bernard, PhD,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. (1) Future Neurology, Future Science Group. Editorial Board Member.Current (2) Inflammation and Regeneration. Guest Editor. 2014 (3) Inflammation and Regeneration. Editorial Board 2013

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NHMRC of Australia; APP1048899;PI, 2013-2015 NHMRC of Australia; APP1069979; PI, 2014-1016 NHMRC of Australia/CIRM; APP1053621, PI, 2012-2015 Victorian Goverment/CIRM; RMI-01739, PI, 2012-2015 Department of Industry,Commonwealth of Australia, 2013-2016

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Eva and Les Erdi AUSiMED Fellowship in Neurological Diseases.

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Raymond A. Sobel, MD and
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Journal of Neuropathology and Experimental Neurology, Editor-in-Chief, 2007-present, Journal of Neuroimmunology, Associate Editor, 2000-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH R01 NS 030843. (PI: V. Kuchroo, subcontract to Dr. Sobel as Co-Investigator (2002-2014) NIH/NIAID R01 AI073737 (PI: S. Zamvil, Subcontract to Dr. Sobel as Co-Investigator) 6/1/09 ? 6/31/14. DOD/CDRMP W81XWH-11-1-0512. PI: B. Zabel. Dr. Sobel is Co-Investigator 9/1/11-8/31/14

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. National Multiple Sclerosis Society (PI: Zamvil)

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Scott S. Zamvil, MD, PhD
    8. Scientific Advisory Boards:

    1. Dr. Zamvil has received honoraria for serving on Data Safety Monitoring Boards for MS trials conducted by BioMS, Teva Pharmaceuticals, Inc. and Eli Lilly and Co. He is a member of the Clinical Advisory Board for the Myelin Repair Foundation.

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. (1) Neurology, Neuroimmunology and Neuroinflammation, Deputy Editor, 2014-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. SSZ has served as a consultant to Biogen Idec, Teva Neuroscience, EMD-Serono, Genzyme, Novartis and Roche.

    Speakers' Bureaus:

    1. Advanced Health Media, 2009-present Biogen Idec, 2009-present

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH RO1 AI073737 NIH RO1 NS 063008

    Research Support, Academic Entities:

    1. NMSS RG 4768A9/1 NMSS RG 5180A11/1 NMSS RG 5179A10/2

    Research Support, Foundations and Societies:

    1. Alexander M. and June L. Maisin Foundation, PI

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Neurology and Program in Immunology (K.L.-H., S.A.S., R.C.W., C.M.S., S.S.Z.), University of California, San Francisco; Multiple Sclerosis Research Group (C.C.A.B.), Australian Regenerative Medicine Institute, Monash University, Clayton, Australia; and Department of Pathology (R.A.S.), Stanford University School of Medicine, CA. Dr. Lehmann-Horn is currently with the Department of Neurology, Klinikum rechts der Isar, Technische Universität München; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
  1. Correspondence to Dr. Zamvil: zamvil{at}ucsf.neuroimmunol.org
View Full Text

Article usage

Article usage: March 2016 to October 2021

AbstractFullPdfSource
Mar 2016383258164Highwire
Apr 20162616143Highwire
Apr 2016011667pmc
May 2016139618Highwire
May 201604534pmc
Jun 2016641216Highwire
Jun 201603216pmc
Jul 2016581319Highwire
Jul 201603017pmc
Aug 2016871211Highwire
Aug 201603913pmc
Sep 20164965Highwire
Sep 20160216pmc
Oct 20163342Highwire
Oct 201603117pmc
Nov 201632814Highwire
Nov 20160147pmc
Dec 20163169Highwire
Dec 201602010pmc
Jan 20172457Highwire
Jan 201701510pmc
Feb 20172725Highwire
Feb 20170121pmc
Mar 20172005Highwire
Mar 20170156pmc
Apr 20172142Highwire
Apr 201771011pmc
May 20172436Highwire
May 2017265pmc
Jun 20172016Highwire
Jun 20173910pmc
Jul 20171233Highwire
Jul 2017264pmc
Aug 20171543Highwire
Aug 2017244pmc
Sep 20171511Highwire
Sep 2017486pmc
Oct 20171425Highwire
Oct 201751412pmc
Nov 20172686Highwire
Nov 201781311pmc
Dec 20179256Highwire
Jan 201814285Highwire
Feb 201810232Highwire
Mar 201810193Highwire
Apr 20188204Highwire
Apr 2018266pmc
May 20182196Highwire
Jun 20180152Highwire
Jun 2018133pmc
Jul 2018185Highwire
Aug 20182183Highwire
Aug 2018497pmc
Sep 20181152Highwire
Oct 20183176Highwire
Nov 20185105Highwire
Dec 20185134Highwire
Jan 2019095Highwire
Feb 20192283Highwire
Mar 201923408Highwire
Apr 201915010Highwire
May 201945814Highwire
Jun 20192168Highwire
Jul 20193136Highwire
Aug 2019267Highwire
Sep 201911410Highwire
Oct 20191816Highwire
Nov 2019179Highwire
Dec 201931918Highwire
Jan 20200911Highwire
Feb 20201144Highwire
Mar 202022415Highwire
Apr 202021410Highwire
May 202031712Highwire
Jun 202011211Highwire
Jul 2020079Highwire
Aug 2020275Highwire
Sep 202031513Highwire
Oct 20200155Highwire
Nov 20202514Highwire
Dec 202041513Highwire
Jan 202121718Highwire
Feb 20211915Highwire
Mar 202141010Highwire
Apr 20214147Highwire
May 20213179Highwire
Jun 20211145Highwire
Jul 202141410Highwire
Aug 202134313Highwire
Sep 202121012Highwire
Oct 202161819Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top

Topics Discussed

Alert Me

Advertisement